The “Shark Tank” co-host says exposure to this market is essential right now.
Read MoreThe firm initiated coverage of nine pot stocks and said these 5 are Buys.
Read MoreAffimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients with […]
Read MoreBoth of these 2 biotechs could see triple-digit gains on the horizon. Here’s why.
Read MoreIf you thought betting against the stock market in a weak earnings season was a good idea, JPMorgan might convince you otherwise.
Read MoreOver the last week or so, I’ve written about a few companies in the Food Products industry that I think offer some interesting possibilities under current market conditions – something that is even more true if the market sees an increase in short-term volatility. Investors are putting a lot of focus on geopolitics right now, […]
Read MoreBest Buy Co. Inc. (BBY) reported Q4 earnings on Wednesday, further demonstrating its stability in the era of Amazon.com Inc. (AMZN) dominance. The brick-and-mortar electronics retailer easily surpassed Wall Street expectations on the top and bottom lines thanks to a series of initiatives under CEO Hubert Joly. While most consumers still choose to purchase their […]
Read More